menu search

Allogene therapeutics announces oral presentation of phase 1 data on allo-501/501a in large b cell lymphoma at the international conference on malignant lymphoma (icml) lugano

Long-Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials demonstrates Potential of Allogeneic CD19 CAR...

June 9, 2023, 10:25 pm

Report: meta demonstrates text-based app to employees while preparing launch

Meta has reportedly demonstrated its upcoming text-based app to employees. The app was shown during an all-hands meeting Thursday (June 8) and was ...

June 9, 2023, 5:30 pm

Successful primary engraftment of trem-cel in first five aml patients demonstrates promise of vor bio’s platform

Patients transplanted with trem-cel achieved primary neutrophil engraftment and high levels of myeloid donor chimerism. Strong investigator enthusiasm...

June 9, 2023, 11:30 am

Technical outlook and review

DXY: The DXY (US Dollar Index) chart demonstrates a bearish momentum, supported by the fact that the pr...

June 9, 2023, 7:30 am

Report shows powerful results from career-connected math

Curriculum demonstrates positive results for student engagement, math performance, and future education...

June 7, 2023, 3:00 pm

Buy 3 june dogs of the dow, watch 4

"The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is...

June 6, 2023, 6:44 pm

Transition metals pinpoints large gold exploration target at jolly gold

Transition Metals Corp (TSX-V:XTM) has provided a salient interpretation of results from fieldwork completed at the company's wholly owned and optione...

June 6, 2023, 11:00 am

Valero energy: keeping a keen eye on diversification reveals solid potential

Valero Energy demonstrates strong fundamentals and commitment to growth through investment and diversif...

June 5, 2023, 10:20 am

Trump’s persistent election result denials demonstrate the need for bitcoin-verified truth

Donald Trump’s tireless 2020 election denials, and the fact that voters don’t know what to believe, demons...

June 3, 2023, 12:14 pm

Nuscale power ($smr) demonstrates emission reducing capabilities of small modular reactors

New research from NuScale Power (NYSE: SMR) has demonstrated the advanced capabilities of NuScale small modular reactors (SMRs) for reducing emissions...

May 31, 2023, 2:06 pm

Why coca-cola, costco, and starbucks are no-brainer buys right now

Coca-Cola is as reliable as you can get for dividend payments. Costco still draws new members and demonstrates...

May 31, 2023, 5:10 am

Mastercard: i was too cautious (rating upgrade)

Mastercard's recent financial performance and double-digit revenue growth in a challenging environment indicate a bullish outlook. MA is well-position...

May 30, 2023, 11:17 pm

Centerspace: rental growth will fuel growth in 2023 and beyond

Centerspace demonstrates strong Q1 2023 performance with a focus on key areas like Minneapolis and Denv...

May 30, 2023, 6:07 am

Decoding sentinelone's ai edge: the next big leap in cybersecurity

SentinelOne, a cybersecurity firm, demonstrates strong growth with a 92% YoY revenue increase in Q4 202...

May 30, 2023, 3:39 am

3 top growth stocks to make you the millionaire next door

The Millionaire Next Door is a timeless book that explores the habits ordinary people use to become millionaires. The book ...

May 29, 2023, 2:47 pm

Macrogenics: non-dilutive funding propels drug candidates (rating upgrade)

MacroGenics demonstrates promise with its drug lorigerlimab for mCRPC treatment, despite a recent 18% s...

May 29, 2023, 2:47 am

Global business intelligence market is set to reach us$ 56.2 billion by the forecast period 2033 end at a cagr of 7.1% | data analysis by future market insights, inc.

The United States is witnessing robust growth in the business intelligence market, with a projected CAGR of 7.0% from 2023 to 2033. By the end of 2033...

May 26, 2023, 11:30 am

Greenland technologies holding corp ceo raymond wang buys 66,500 shares

On May 22, 2023, Raymond Wang, CEO of Greenland Technologies Holding Corp ( GTEC , Financial), purchased 66,500 shares of the company's stock. This mo...

May 25, 2023, 10:26 pm

Updated linvoseltamab (bcmaxcd3) data from pivotal trial demonstrates early, deep and durable responses in patients with heavily pre-treated multiple myeloma

71% objective response rate, with 59% of patients achieving a very good partial response or better at the recommended 200 mg dose, per new data to be ...

May 25, 2023, 9:05 pm

Insider buying: ceo pablo legorreta acquires 150,000 shares of royalty pharma plc (rprx)

On May 24, 2023, Pablo Legorreta, CEO, Chairman of the Board, and 10% Owner of Royalty Pharma PLC ( RPRX , Financial), purchased 150,000 shares of the...

May 25, 2023, 6:06 pm


Search within

Pages Search Results: